Group 1: Momentum Investing Overview - Momentum investing involves following a stock's recent trend, with the strategy of buying high and selling higher, capitalizing on established price movements [1] - The Zacks Momentum Style Score helps investors identify stocks with momentum by focusing on key metrics [2] Group 2: Aveanna Healthcare (AVAH) Analysis - Aveanna Healthcare currently holds a Momentum Style Score of A and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] - Over the past week, AVAH shares increased by 15.31%, significantly outperforming the Zacks Medical - Outpatient and Home Healthcare industry, which rose by 1.01% [6] - In a longer timeframe, AVAH shares have risen by 33.4% over the past quarter and 42.27% over the past year, while the S&P 500 only increased by 7.87% and 15.7%, respectively [7] Group 3: Trading Volume and Earnings Outlook - The average 20-day trading volume for AVAH is 1,672,211 shares, indicating a bullish sign with rising stock prices [8] - Over the past two months, three earnings estimates for AVAH have increased, raising the consensus estimate from $0.22 to $0.35 [10] - The positive earnings revisions suggest a promising outlook for AVAH, reinforcing its status as a 1 (Strong Buy) stock with a Momentum Score of A [12]

Core Points - Extendicare Inc. declared a cash dividend of C$0.042 per common share for July 2025, payable on August 15, 2025, to shareholders of record on July 31, 2025 [1] - The dividend is classified as an "eligible dividend" under the Income Tax Act (Canada) [1] Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating under various brands including Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network [2] - The company operates 99 long-term care homes, with 59 owned and 40 under management contracts [2] - Extendicare delivers approximately 11.2 million hours of home health care services annually and provides group purchasing services for about 148,200 beds across Canada [2] - The company employs around 26,500 qualified and dedicated team members focused on high-quality care [2]

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of a growing seniors' population, inspired by our mission to provide people with the care they need, wherever they call home. We operate a network of 99 long-term care homes (59 owned, 40 under management contracts), deliver approximately 11.2 million hours of home healt ...

Core Viewpoint - Extendicare Inc. has received approval from the Toronto Stock Exchange for the renewal of its normal course issuer bid, allowing the company to repurchase up to 7,281,193 common shares, which is 10% of its public float [1][4] Group 1: NCIB Details - The NCIB will commence on July 2, 2025, and will continue until July 1, 2026, or until the bid is completed [2] - Daily purchases under the NCIB will be limited to 44,803 common shares based on the average daily trading volume of 179,213 shares over the last six months [2] - All common shares purchased under the NCIB will be cancelled [3] Group 2: Rationale and Strategy - The board of directors believes that purchasing common shares may be an attractive use of corporate funds based on market conditions and share price [4] - The company has not purchased any shares under its previous NCIB, which allowed for the purchase of up to 7,159,997 common shares [5] Group 3: Automatic Purchase Plan - Extendicare has established an automatic purchase plan with its designated broker to facilitate share purchases during regulatory black-out periods [6] Group 4: Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 99 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [7] - The company employs around 26,500 qualified team members dedicated to providing high-quality care [7]

MARKHAM, Ontario, June 16, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services ...

Core Points - Extendicare Inc. has completed the acquisition of nine "Class C" long-term care homes and a parcel of vacant land from Revera Inc. effective June 1, 2025 [1] - The total consideration for the transaction was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in liabilities [2] - The acquired homes include a total of 822 long-term care beds and 574 retirement beds across various locations in Ontario and Manitoba [3] Financial Details - The purchase price was funded from cash on hand, excluding transaction costs [2] - The liabilities assumed include government funding reimbursement obligations and committed capital maintenance project obligations [2] Operational Insights - Carlingview Manor is undergoing redevelopment into a new 320-bed long-term care home, owned by a joint venture between Extendicare and Axium [4] - Extendicare operates a network of 99 long-term care homes, providing approximately 11.2 million hours of home health care services annually [5] - The company employs around 26,500 qualified team members dedicated to delivering high-quality care [5]

Core Points - Extendicare Inc. held its annual and special meeting of shareholders on May 27, 2025, where various matters were voted on [1] - A total of 47,282,730 common shares were represented at the meeting, accounting for 56.41% of the outstanding shares [2] Group 1: Election of Directors - Nine nominees were elected as directors to serve until the next annual meeting [3] - The voting results showed high approval rates for the nominees, with votes for ranging from 94.08% to 99.74% [4] Group 2: Appointment of Auditors - KPMG LLP was appointed as the auditors of the Company until the next annual meeting, with 87.18% of votes in favor [5][6] Group 3: Long Term Incentive Plan - The resolution to approve unallocated entitlements under Extendicare's Long Term Incentive Plan was passed with 97.04% approval [7][8] Group 4: Executive Compensation - A non-binding advisory resolution regarding the Company's approach to executive compensation was approved, receiving 94.48% of votes in favor [9][10][11] Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 122 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [12]

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, inves ...

Core Viewpoint - Nova Leap Health Corp. reported its financial results for Q1 2025, showing revenue growth but a decline in Adjusted EBITDA and net income, while focusing on acquisitions and expansion in the home health care sector [2][4][6]. Financial Performance - Q1 2025 revenues reached $7,093,624, marking a 7.7% increase from Q4 2024 and a 10.3% increase from Q1 2024 [2]. - Adjusted EBITDA for Q1 2025 was $289,060, a decrease of 30.0% from Q4 2024 and 20.1% from Q1 2024 [4][12]. - The gross profit margin was stable at 39.0% in Q1 2025, compared to 39.1% in Q4 2024 and 38.0% in Q1 2024 [7]. Operational Highlights - The company generated an income from operating activities of $75,152 in Q1 2025, down from $186,709 in Q1 2024 and $221,184 in Q4 2024 [7][12]. - A net loss of $78,299 was recorded in Q1 2025, contrasting with net income of $473,073 in Q1 2024 and $886,268 in Q4 2024 [7]. Acquisition Strategy - The company completed two acquisitions in Nova Scotia in January and May 2025, totaling CAD$1,770,000, financed through loans and cash [7][8]. - Nova Scotia has become the fastest-growing segment of the business due to these acquisitions [6]. Future Outlook - The company anticipates setting a record for quarterly revenues in Q2 2025, surpassing the previous record from Q1 2022 [6]. - Despite expected revenue growth, Adjusted EBITDA may lag due to ongoing investments in operations and expansion [9]. Financial Position - As of March 31, 2025, the company had available cash of $1,333,115 and access to an unutilized revolving credit facility of $1,043,406 [7]. - Total demand loans and promissory notes outstanding were $2,526,202, resulting in a leverage ratio of 1.70 times to Adjusted EBITDA for the 12-month period ending March 31, 2025 [7]. Industry Context - Nova Leap operates in the rapidly growing home health care services sector, focusing on individual and family-centered care, particularly for dementia patients [10]. - The company has been recognized for its growth, ranking 42 in Canada's Top Growing Companies in 2021 [10].

Company Overview - Extendicare Inc. is a leading provider of care and services for seniors across Canada, operating under various brands including Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network [2] - The company operates a network of 122 long-term care homes, with 51 owned and 71 under management contracts [2] - Extendicare delivers approximately 11.0 million hours of home health care services annually and provides group purchasing services to third parties representing around 146,300 beds across Canada [2] - The company employs approximately 24,000 qualified and dedicated team members focused on delivering high-quality care and services [2] Recent Financial Announcement - Extendicare has declared a cash dividend of C$0.042 per common share for March 2025, payable on April 15, 2025, to shareholders of record as of March 31, 2025 [1]